Embedded SMO Model Delivering Predictable Enrollment and                                            Consistent Study Execution

Research Management Partners (RMP) integrates directly within active clinical practices across Florida and Puerto Rico, combining experienced investigators, centralized operations, and real-time oversight to accelerate study start-up, improve enrollment performance, and ensure high-quality data delivery.

Network Overview

• 30+ Active Research Sites

• 150+ Clinical Trials Conducted

• 100k+ Accessible Patient Population

• Phase I–IV Experience Across Multiple Therapeutic Areas

​

A Different Kind of SMO — Built for Sponsor Performance

Unlike traditional site networks or virtual SMO models, RMP operates directly within clinical practices, embedding research infrastructure at the site level while maintaining centralized operational control.

This model enables sponsors and CROs to reduce variability, improve oversight, and achieve more predictable outcomes across all participating sites.

What Sponsors Gain Working with RMP

Reduced Monitoring Burden
Centralized oversight and real-time quality control reduce the need for intensive on-site monitoring while maintaining visibility across all study activities.

Fewer Protocol Deviations
Standardized SOPs and continuous quality processes ensure consistent protocol adherence across all sites.

Predictable Enrollment
Direct access to active patient populations enables accurate feasibility assessments and reliable enrollment timelines.

Scalable Multi-Site Execution
Unified infrastructure supports consistent performance across a growing network of clinical research sites.

Embedded SMO Model with Centralized Execution

RMP combines the strengths of an SMO and an MSO by embedding research operations directly within clinical practices. All investigators operate under a centralized framework that includes regulatory oversight, SOP governance, study start-up coordination, and integrated research technologies such as CTMS and eSource platforms.

This structure minimizes delays, reduces operational risk, and ensures standardized execution across all sites.

Therapeutic Expertise

Psychiatry • Gastroenterology • Pulmonology • Cardiology • Endocrinology • Rheumatology • Infectious Diseases • Neurology • Dermatology • Nephrology

Representative Experience

RMP investigators have collectively contributed to more than 150 industry-sponsored clinical trials across Phase I–IV programs, including studies in:

• Major Depressive Disorder, Schizophrenia, Bipolar Disorder

• COPD, Severe Asthma, Pulmonary Fibrosis

• Crohn’s Disease, Ulcerative Colitis, NASH

• Diabetes, Cardiovascular Disease, Metabolic Disorders

• Rheumatology, Infectious Diseases, Neurology

View full investigator experience →

Simple Engagement Process

1. Submit protocol or feasibility request

2. RMP evaluates site fit across its network

3. Centralized start-up and regulatory activation

4. Consistent execution across selected sites

Looking for Reliable Site Performance and Faster Study Execution?

Partner with Research Management Partners to access experienced investigators, diverse patient populations, and a centralized operational model designed to deliver consistent, high-quality results across every phase of clinical development.

                                                 Submit a Protocol or Feasibility Request

​

                                                  Response within 48 hours
                                                   📩 admin@rmpsmo.com